Form D · Pharmaceuticals
ACADIA PHARMACEUTICALS INC
San Diego, CA · CIK 0001070494
Offering snapshot reported Jan 2, 2013 · SEC filing
- Reported sold
- $86.4M Offering amount: $86.4M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 17, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 2, 2013 | Initial | $86,385,000 | No comparison | 29 | SEC filing |
| Jan 24, 2011 | Initial | $21,069,109 | No comparison | 5 | SEC filing |
| Aug 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 10, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 24, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $5.63M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-189257
Includes amounts which may be received by the Company upon the exercise of outstanding warrants (assuming no cashless exercise).
Includes reimbursement of certain costs and fees.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| JEFFERIES & COMPANY, INC. | 2347 | JEFFERIES & COMPANY, INC. · CRD 2347 |
| COWEN AND COMPANY, LLC | 7616 | COWEN AND COMPANY, LLC · CRD 7616 |
Source: Form D, filed Jan 2, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas H Aasen | Executive |
| Glenn F Baity | Executive |
| Michael T Borer | Director |
| Laura A Brege | Director |
| Mary Ann Gray | Director |
| Uli Hacksell | Director, Executive |
| Leslie L Iversen | Director |
| Lester J Kaplan | Director |
| Roger G Mills | Executive |
| Torsten Rasmussen | Director |
| William M Wells | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3911 Sorrento Valley Blvd
San Diego, CA, 92121
San Diego, CA, 92121